Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
---|---|---|---|---|---|---|---|---|---|
7.12% | 0 | 58.46% | 2.55% | 2050-11-13 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
6.61% | 0 | 67.10% | 2.35% | 2040-11-13 | 750 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
6.44% | 0 | 72.17% | 3.90% | 2062-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4036425Celgene Corporation 5.25% 15-AUG-2043 | 6.40% | 65 K | 90.24% | 5.25% | 2043-08-15 | 4.06 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
BBMY4124214Celgene Corporation 4.625% 15-MAY-2044 | 6.38% | 20 K | 84.86% | 4.63% | 2044-05-15 | 3.69 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
6.37% | 0 | 73.42% | 3.70% | 2052-03-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4275603Celgene Corporation 5.0% 15-AUG-2045 | 6.24% | 348 K | 88.78% | 5.00% | 2045-08-15 | 15.71 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
6.23% | 5.5 M | 75.06% | 3.25% | 2042-08-01 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4597874Celgene Corporation 4.55% 20-FEB-2048 | 6.19% | 20 K | 84.30% | 4.55% | 2048-02-20 | 37.2 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
6.15% | 3.9 M | 81.40% | 4.25% | 2049-10-26 | 3.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
6.13% | 0 | 78.46% | 3.55% | 2042-03-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4560589Celgene Corporation 4.35% 15-NOV-2047 | 6.09% | 10 K | 83.43% | 4.35% | 2047-11-15 | 13.57 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
6.08% | 345 K | 83.51% | 4.35% | 2047-11-15 | 1.24 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY3685700Celgene Corporation 5.7% 15-OCT-2040 | 5.98% | 290 K | 97.64% | 5.70% | 2040-10-15 | 2.3 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
5.92% | 0 | 87.25% | 4.50% | 2044-03-01 | 341.52 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.90% | 0 | 97.04% | 5.65% | 2064-02-22 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.90% | 400 K | 86.82% | 4.55% | 2048-02-20 | 1.24 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.82% | 1.01 M | 89.12% | 4.63% | 2044-05-15 | 744.72 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.80% | 1.23 M | 86.87% | 4.13% | 2039-06-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.77% | 0 | 97.64% | 5.55% | 2054-02-22 | 2.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.72% | 221 K | 93.21% | 5.00% | 2045-08-15 | 741.72 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.71% | 0 | 108.32% | 6.40% | 2063-11-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.61% | 0 | 107.00% | 6.25% | 2053-11-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.58% | 0 | 99.28% | 5.50% | 2044-02-22 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.54% | 30 K | 119.38% | 6.88% | 2097-08-01 | 62.42 M USD | 1,000.00 USD | 1,000.00 USD | Bristol Myers Squibb Co. | |
5.50% | 60 K | 97.66% | 5.25% | 2043-08-15 | 218.37 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.37% | 0 | 87.58% | 2.95% | 2032-03-15 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.33% | 50 K | 103.16% | 5.70% | 2040-10-15 | 151.01 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.21% | 30 K | 107.18% | 6.13% | 2038-05-01 | 219.25 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.19% | 0 | 100.06% | 5.20% | 2034-02-22 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.18% | 0 | 105.06% | 5.88% | 2036-11-15 | 279.22 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4560450Celgene Corporation 3.45% 15-NOV-2027 | 5.12% | 980 K | 95.87% | 3.45% | 2027-11-15 | 16.55 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
5.09% | 484 K | 83.80% | 1.45% | 2030-11-13 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.04% | 0 | 105.26% | 5.90% | 2033-11-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.88% | 6.85 M | 94.57% | 3.40% | 2029-07-26 | 2.37 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.87% | 0 | 101.05% | 5.10% | 2031-02-22 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.81% | 0 | 104.35% | 5.75% | 2031-02-01 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.76% | 0 | 100.49% | 4.90% | 2029-02-22 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.75% | 0 | 97.20% | 3.25% | 2027-02-27 | 512.28 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.70% | 0 | 91.28% | 1.13% | 2027-11-13 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4597873Celgene Corporation 3.9% 20-FEB-2028 | 4.66% | 940 K | 97.99% | 3.90% | 2028-02-20 | 43.84 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
4.65% | 417 K | 100.30% | 4.95% | 2026-02-20 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.62% | 1.8 M | 98.10% | 3.90% | 2028-02-20 | 1.45 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.53% | 0 | 100.41% | 4.95% | 2026-02-20 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.53% | 5 K | 97.35% | 3.45% | 2027-11-15 | 517.67 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.51% | 0 | 100.72% | 4.90% | 2027-02-22 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.49% | 596 K | 98.36% | 3.20% | 2026-06-15 | 1.74 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.41% | 7.67 M | 97.33% | 0.75% | 2025-11-13 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.13% | 0 | 99.88% | 3.88% | 2025-08-15 | 228.73 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.03% | 100 K | 104.57% | 6.80% | 2026-11-15 | 255.95 M USD | 1,000.00 USD | 1,000.00 USD | Bristol Myers Squibb Co. | |
3.30% | 0 | 88.12% | 1.75% | 2035-05-15 | 575 M EUR | 1,000.00 EUR | 100,000.00 EUR | Bristol Myers Squibb Co. | |
2.96% | 0 | 99.50% | 1.00% | 2025-05-15 | 575 M EUR | 1,000.00 EUR | 100,000.00 EUR | Bristol Myers Squibb Co. | |
2.47% | 0 | 130.24% | 4.25% | 2049-10-26 | 500 K USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
2.39% | 0 | 122.76% | 4.13% | 2039-06-15 | 4.4 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
2.35% | 0 | 141.76% | 5.00% | 2045-08-15 | 1 K USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
2.32% | 0 | 137.60% | 4.55% | 2048-02-20 | 9.5 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
2.27% | 0 | 104.25% | 3.20% | 2026-06-15 | 5.95 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
1.47% | 0 | 116.80% | 3.90% | 2028-02-20 | 6.07 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
1.33% | 0 | 116.69% | 3.40% | 2029-07-26 | 26.56 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
1.28% | 0 | 114.77% | 3.45% | 2027-11-15 | 67 K USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |